Eileen G Fowler1, Loretta A Staudt1, Kent R Heberer1, Susan E Sienko2, Cathleen E Buckon2, Anita M Bagley3, Michael D Sussman2, Craig M McDonald3,4. 1. Department of Orthopaedic Surgery, University of California Los Angeles, 22-70 Rehab Center, 1000 Veteran Avenue, Los Angeles, California, 90095-1795, USA. 2. Shriners Hospitals for Children Portland, Portland, Oregon, USA. 3. Shriners Hospitals for Children Northern California, Sacramento, California, USA. 4. University of California Davis Medical Center, Sacramento, California, USA.
Abstract
INTRODUCTION: Natural history studies for Duchenne muscular dystrophy (DMD) have not included measures of community ambulation. METHODS: Step activity (SA) monitors quantified community ambulation in 42 boys (ages 4-16 years) with DMD with serial enrollment up to 5 years by using a repeated-measures mixed model. Additionally, data were compared with 10-meter walk/run (10mWR) speed to determine validity and sensitivity. RESULTS: There were significant declines in average strides/day and percent strides at moderate, high and pediatric high rates as a function of age (P < 0.05). Significant correlations for 10mWR versus high and low stride rates were found at baseline (P < 0.05). SA outcomes were sensitive to change over 1 year, but the direction and parameter differed by age group (younger vs. older). Changes in strides/day and percentages of high frequency and low frequency strides correlated significantly with changes in 10mWR speed (P < 0.05). DISCUSSION: Community ambulation data provide valid and sensitive real-world measures that may inform clinical trials. Muscle Nerve 57: 401-406, 2018.
INTRODUCTION: Natural history studies for Duchenne muscular dystrophy (DMD) have not included measures of community ambulation. METHODS: Step activity (SA) monitors quantified community ambulation in 42 boys (ages 4-16 years) with DMD with serial enrollment up to 5 years by using a repeated-measures mixed model. Additionally, data were compared with 10-meter walk/run (10mWR) speed to determine validity and sensitivity. RESULTS: There were significant declines in average strides/day and percent strides at moderate, high and pediatric high rates as a function of age (P < 0.05). Significant correlations for 10mWR versus high and low stride rates were found at baseline (P < 0.05). SA outcomes were sensitive to change over 1 year, but the direction and parameter differed by age group (younger vs. older). Changes in strides/day and percentages of high frequency and low frequency strides correlated significantly with changes in 10mWR speed (P < 0.05). DISCUSSION: Community ambulation data provide valid and sensitive real-world measures that may inform clinical trials. Muscle Nerve 57: 401-406, 2018.
Authors: David J Birnkrant; Katharine Bushby; Carla M Bann; Susan D Apkon; Angela Blackwell; David Brumbaugh; Laura E Case; Paula R Clemens; Stasia Hadjiyannakis; Shree Pandya; Natalie Street; Jean Tomezsko; Kathryn R Wagner; Leanne M Ward; David R Weber Journal: Lancet Neurol Date: 2018-02-03 Impact factor: 44.182
Authors: Donovan J Lott; Tanja Taivassalo; Claudia R Senesac; Rebecca J Willcocks; Ann M Harrington; Kirsten Zilke; Hilary Cunkle; Catherine Powers; Erika L Finanger; William D Rooney; Gihan I Tennekoon; Krista Vandenborne Journal: Muscle Nerve Date: 2020-11-27 Impact factor: 3.217
Authors: Jacob A Kaslow; Andrew G Sokolow; Thomas Donnelly; Maciej S Buchowski; Bruce M Damon; Larry W Markham; W Bryan Burnette; Jonathan H Soslow Journal: Neuromuscul Disord Date: 2022-02-04 Impact factor: 3.538
Authors: Kavya S Nair; Donovan J Lott; Sean C Forbes; Alison M Barnard; Rebecca J Willcocks; Claudia R Senesac; Michael J Daniels; Ann T Harrington; Gihan I Tennekoon; Kirsten Zilke; Erika L Finanger; Richard S Finkel; William D Rooney; Glenn A Walter; Krista Vandenborne Journal: J Neuromuscul Dis Date: 2022
Authors: Laurent Servais; Eric Camino; Aude Clement; Craig M McDonald; Jacek Lukawy; Linda P Lowes; Damien Eggenspieler; Francesca Cerreta; Paul Strijbos Journal: Digit Biomark Date: 2021-08-05
Authors: Adrienne Samani; Rylie M Hightower; Andrea L Reid; Katherine G English; Michael A Lopez; J Scott Doyle; Michael J Conklin; David A Schneider; Marcas M Bamman; Jeffrey J Widrick; David K Crossman; Min Xie; David Jee; Eric C Lai; Matthew S Alexander Journal: Life Sci Alliance Date: 2022-05-05
Authors: Aaron S Zelikovich; Mattia Quattrocelli; Isabella M Salamone; Nancy L Kuntz; Elizabeth M McNally Journal: Sci Rep Date: 2019-04-08 Impact factor: 4.379
Authors: David Arteaga; Thomas Donnelly; Kimberly Crum; Larry Markham; Mary Killian; W Bryan Burnette; Jonathan Soslow; Maciej S Buchowski Journal: J Neuromuscul Dis Date: 2020
Authors: Matthew F Jacques; Gladys L Onambele-Pearson; Neil D Reeves; Georgina K Stebbings; Jonathon Smith; Christopher I Morse Journal: J Cachexia Sarcopenia Muscle Date: 2018-10-19 Impact factor: 12.910